v3.26.1
Schedule of Operations by Reportable Segment (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Revenue $ 3,604,000 $ 5,285,000 $ 7,934,000 $ 10,237,000
Operating expense 7,390,000 8,710,000 17,208,000 17,388,000
Operating income (loss) (3,786,000) (3,425,000) (9,274,000) (7,151,000)
Other income (expense) 21,000 4,000 7,000 10,000
Net income (loss) from operations before taxes (5,035,000) (2,607,000) (11,262,000) (7,969,000)
Operating Segments [Member]        
Segment Reporting [Line Items]        
Revenue 3,604,000 5,285,000 7,934,000 10,237,000
Cost of revenue 4,519,000 5,489,000 10,052,000 10,665,000
Gross profit (loss) (915,000) (204,000) (2,118,000) (428,000)
Operating expense 2,871,000 3,221,000 7,156,000 6,723,000
Operating income (loss) (3,786,000) (3,425,000) (9,274,000) (7,151,000)
Other income (expense) (1,249,000) 818,000 (1,988,000) (818,000)
Net income (loss) from operations before taxes (5,035,000) (2,607,000) (11,262,000) (7,969,000)
Operating Segments [Member] | Product Packaging [Member]        
Segment Reporting [Line Items]        
Revenue 3,274,000 4,288,000 7,438,000 8,286,000
Cost of revenue 3,357,000 4,094,000 7,796,000 7,895,000
Gross profit (loss) (83,000) 194,000 (358,000) 391,000
Operating expense 873,000 754,000 1,772,000 1,464,000
Operating income (loss) (956,000) (560,000) (2,130,000) (1,073,000)
Other income (expense) (28,000) (37,000) (59,000) (75,000)
Net income (loss) from operations before taxes (984,000) (597,000) (2,189,000) (1,148,000)
Operating Segments [Member] | Commercial Banking [Member]        
Segment Reporting [Line Items]        
Revenue 6,000 9,000 11,000 30,000
Cost of revenue 234,000 212,000
Gross profit (loss) 6,000 (225,000) 11,000 (182,000)
Operating expense 94,000 75,000 170,000 140,000
Operating income (loss) (88,000) (300,000) (159,000) (322,000)
Other income (expense) 37,000 (170,000) 45,000 (416,000)
Net income (loss) from operations before taxes (51,000) (470,000) (114,000) (738,000)
Operating Segments [Member] | Biotechnology [Member]        
Segment Reporting [Line Items]        
Revenue 3,000 7,000 10,000 21,000
Cost of revenue 1,000 3,000 1,000 4,000
Gross profit (loss) 2,000 4,000 9,000 17,000
Operating expense 699,000 1,195,000 3,004,000 2,261,000
Operating income (loss) (697,000) (1,191,000) (2,995,000) (2,244,000)
Other income (expense) 2,000 3,000 7,000 46,000
Net income (loss) from operations before taxes (695,000) (1,188,000) (2,988,000) (2,198,000)
Operating Segments [Member] | Securities [Member]        
Segment Reporting [Line Items]        
Revenue 321,000 981,000 475,000 1,900,000
Cost of revenue 1,161,000 1,165,000 2,255,000 2,561,000
Gross profit (loss) (840,000) (184,000) (1,780,000) (661,000)
Operating expense 331,000 737,000 649,000 899,000
Operating income (loss) (1,171,000) (921,000) (2,429,000) (1,560,000)
Other income (expense) (177,000) 107,000 170,000 (970,000)
Net income (loss) from operations before taxes (1,384,000) (814,000) (2,259,000) (2,530,000)
Operating Segments [Member] | Corporate Segment [Member]        
Segment Reporting [Line Items]        
Revenue
Cost of revenue (7,000) (7,000)
Gross profit (loss) 7,000 7,000
Operating expense 874,000 460,000 1,561,000 1,959,000
Operating income (loss) (874,000) (453,000) (1,561,000) (1,952,000)
Other income (expense) (1,083,000) 915,000 (2,151,000) 597,000
Net income (loss) from operations before taxes $ (1,957,000) $ 462,000 $ (3,712,000) $ (1,355,000)